To optimize the discovery and development of TB vaccines, TBVI facilitates the exchange of knowledge among its international partners. We create an enabling environment for the partners to promote knowledge-sharing through (scientific) meetings, publication in scientific and non-scientific journals, formal and informal networking. We also participate in global meetings on TB, TB R&D and TB vaccine R&D, providing technical inputs to make an evidence-based case for TB vaccine R&D to be put higher on the global agenda and for increased investment.

TBVI organises meetings to bring together researchers, developers, policy makers, funders and other experts from different relevant disciplines, to exchange knowledge and to stimulate innovative approaches in TB vaccine R&D.

To stimulate innovative ideas, cross-cutting research areas are on the agenda to be discussed with partners and external researchers with expertise in a diversity of disciplines. We organise these meetings in collaboration with our partners.

Knowledge exchange meetings encourage and enable scientists and researchers to bring forward their innovative ideas, concepts, technologies and strategies for a creative “bottom up” approach to vaccine- and biomarker discovery and development. This often leads to new collaborations and new initiatives for projects. We constantly seek funding opportunities and initiate new projects when new funding opportunities arise.

TBVI’s Annual symposium in Les Diablerets 

An important venue for knowledge sharing is the traditional TBVI Annual Symposium in Les Diablerets, Switzerland. Since 2005, TBVI has brought together TB scientists in the Swiss mountain resort of Les Diablerets, located upwards from the lake of Geneva. Over the years, this somewhat secluded location has facilitated a ‘TB group’ spirit that has led to many new ideas, projects and collaborations.

Link to
LD2024 – news item that includes all presentations and TBVI Talent Award
LD2023 – news item